Published in Ophthalmology on February 28, 2013
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev (2014) 1.76
Funduscopic results after 4-year follow-up treatment with ranibizumab for age-related macular degeneration in a region of Spain. BMC Ophthalmol (2014) 0.76
Comparison of intravitreal ranibizumab between phakic and pseudophakic neovascular age-related macular degeneration patients: Two-year results. Saudi J Ophthalmol (2014) 0.75
Comparison of vitrectomized with nonvitrectomized eyes after subtenon injection of triamcinolone acetonide to treat diabetic macular edema: Retrospective comparative Analysis of an interventional case series. Indian J Ophthalmol (2017) 0.75
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology (2012) 6.35
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology (2007) 3.11
Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol (2007) 3.00
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology (2013) 2.99
Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology (2011) 2.43
Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology (2007) 2.41
Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med (2002) 2.39
Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion. Ophthalmology (2012) 1.90
Echinacea and truth in labeling. Arch Intern Med (2003) 1.54
Performance of a new screening spirometer at a community health fair. Respir Care (2002) 1.51
Anti-vascular endothelial growth factor therapy for diabetic macular edema. Ther Adv Endocrinol Metab (2013) 1.34
Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration. Ophthalmology (2011) 1.33
The genome sequence of the most widely cultivated cacao type and its use to identify candidate genes regulating pod color. Genome Biol (2013) 1.26
Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography. Ophthalmology (2013) 1.17
Molecular mechanism for orienting membrane and actin dynamics to nascent cell-cell contacts in epithelial cells. J Biol Chem (2002) 1.17
Long-term effects of ranibizumab on diabetic retinopathy severity and progression. Arch Ophthalmol (2012) 1.16
Expectation of pregnancy outcome among mature women. Am J Obstet Gynecol (2005) 1.01
Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study. Retina (2010) 1.00
Precise CD4 T-cell counting using red diode laser excitation: for richer, for poorer. Cytometry (2002) 0.99
Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials. Am J Ophthalmol (2010) 0.98
Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation. Radiat Res (2004) 0.97
Seniors' preferences for cancer screening and medication use based on absolute risk reduction. J Gerontol A Biol Sci Med Sci (2002) 0.97
West Nile virus: round five. CMAJ (2004) 0.96
Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy. Photochem Photobiol (2002) 0.94
Anatomical measures as predictors of visual outcomes in ranibizumab-treated eyes with neovascular age-related macular degeneration. Retina (2013) 0.91
Fixed Monthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular Degeneration. J Ophthalmol (2012) 0.90
Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy. Photochem Photobiol (2003) 0.88
Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trials. Am J Ophthalmol (2011) 0.88
Low albumin level in the emergency department: a potential independent predictor of delayed mortality in blunt trauma. J Emerg Med (2003) 0.87
A flow cytometric protocol for detection of Cryptosporidium spp. Cytometry A (2008) 0.86
Choroidopathy and kidney disease: a case report and review of the literature. Cases J (2009) 0.86
Simplified cytometry for routine monitoring of infectious diseases. Cytometry B Clin Cytom (2008) 0.82
Amniocentesis in the management of preterm premature rupture of the membranes: a retrospective cohort analysis. J Matern Fetal Neonatal Med (2008) 0.81
Dosing regimen and the frequency of macular hemorrhages in neovascular age-related macular degeneration treated with ranibizumab. Retina (2010) 0.81
A Cautionary Tale of Downloading Public Health in Ontario: What Does It Say about the Need for National Standards for More Than Doctors and Hospitals? Healthc Policy (2006) 0.80
A genetically anchored physical framework for Theobroma cacao cv. Matina 1-6. BMC Genomics (2011) 0.78
Laser-assisted penetration of topical anesthetic in adults. Arch Dermatol (2003) 0.77
Ranibizumab for diabetic macular edema. Author reply. Ophthalmology (2013) 0.75
Public health response to striking solid waste management. J Environ Health (2011) 0.75
Excision only for tubular carcinoma of the breast. Breast J (2005) 0.75
CYTOMETRY 2012--what would Ehrlich do? Cytometry A (2012) 0.75
Lumpectomy and breast radiotherapy in breast cancer patients with a family history of breast cancer, ovarian cancer, or both. Breast J (2002) 0.75
Indicated vs. routine prenatal urine chemical reagent strip testing. J Reprod Med (2007) 0.75
Why do some women refuse to allow male residents to perform pelvic exams? Acad Med (2002) 0.75
The effect of fellow eye visual acuity on visual acuity of study eyes receiving ranibizumab for age-related macular degeneration. Retina (2012) 0.75